Press releases

  • 2020-07-06

    NeoDynamics restarts patient recruitment to UK COMPULSE Study to optimize diagnosis of breast cancer

    STOCKHOLM - July 6, 2020. NeoDynamics AB (Spotlight Stock Market: NEOD), announces that the Company restarts patient recruitment to the UK COMPULSE Study following a temporary pause imposed by the COVID-19 pandemic. Read more
  • 2020-05-26

    NeoDynamics AB (publ) First Quarter 2020

    Somewhat higher development cost, but mainly in line Read more
  • 2020-02-05

    NeoDynamics AB (publ) full-year report 2019

    Summing up a productive 2019 Read more